One year survival of HIV-infected veterans with CD4 &lt; 100 cells/mm3: data from a veteran cohort (Q33634206)

28 July 2017

One year survival of HIV-infected veterans with CD4 < 100 cells/mm3: data from a veteran cohort (English)

1 reference

28 July 2017

0 references

Katharine Breaux

1

1 reference

28 July 2017

Susmitha Gadde

series ordinal

2

1 reference

28 July 2017

Edward A Graviss

series ordinal

3

1 reference

28 July 2017

Maria C Rodriguez-Barradas

series ordinal

4

1 reference

28 July 2017

1 July 2010

1 reference

28 July 2017

1 reference

28 July 2017

22

1 reference

28 July 2017

886-894

1 reference

28 July 2017

7

1 reference

Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

28 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

The aging of the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Estimating the proportion of patients infected with HIV who will die of comorbid diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Delayed presentation for human immunodeficiency virus (HIV) care among veterans: a problem of access or screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Retention in care: a challenge to survival with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

The impact of integrated HIV care on patient health outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Trends in perimortal conditions and mortality rates among HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Veterans Aging Cohort Study (VACS): Overview and description

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

The Veterans Affairs Healthcare System: A unique laboratory for observational and interventional research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

HIV disease and advanced age: an increasing therapeutic challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

The effect of hepatitis C on progression to AIDS before and after highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540120903499162

10.1080/09540120903499162

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference